•  
  •  
  •  
  •  

2025-09-03 08:47:36

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes

Keywords Selected:  Inspection

Stock Report

  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility
  • Concord Biotech Ltd announces successful completion EU GMP inspection at its API facility
  • EIR from USFDA, for Shilpa Medicare Ltd. Unit VI, Bengaluru.
  • Shilpa Pharma Lifesciences Limited, Unit-1, ANVISA Audit from Brazil
  • Granules India Ltd receives 1 observation from USFDA for Chantilly facility
  • SMS Pharmaceuticals Ltd successfully completes USFDA inspection at Central Laboratory Analytical Services
  • Gland Pharma Ltd receives EIR from US FDA for JNPC Facility, Visakhapatnam
  • Unichem Laboratories Ltd receives Form 483 from USFDA with 3 observations for Roha API facility
  • NATCO Pharma Ltd announces conclusion of USFDA inspection at Pharma Division, Kothur
  • U.S. FDA inspection at Glenmark Pharma's Facility at Monroe, North Carolina, USA
  • USFDA conducts GCP inspection at Syngene International Ltd's facility at Semicon Park, Bengaluru
  • Sun Pharma gets 8 observations from USFDA for Halol facility
  • Syngene International Ltd updates on USFDA inspection at Biocon Park, SEZ, Bengaluru
  • USFDA inspection at the API manufacturing plant located in Mekaguda, Hyderabad
  • Piramal Pharma Ltd completes USFDA inspection of Aurora facility with Zero Form-483 observations
  • USFDA completes GMP inspection at Dr. Reddy's Laboratories Ltd's API Middleburgh facility
  • Innoxel Lifesciences Pvt. Ltd. Successfully Completes U.S. FDA Inspection
  • Neuland Laboratories Ltd completes USFDA inspection at Unit 2
  • USFDA Inspection at Concord Biotech Ltd's API facility at Dholka
  • USFDA inspection at manufacturing facility of Marksans Pharma's subsidiary Time-Cap Laboratories, Inc.
  • Closure of USFDA inspection at Zydus' API Unit at Dabhasa, Gujarat
  • Update on USFDA inspection at manufacturing facility of Medispray in Kundaim, Goa, India
  • Laurus Labs Limited receives EIR for API facility Unit-4

Latest Post

  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024